Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Trial to Assess the Safety and Pharmacokinetics of a Single Ascending Dose (SAD) of N-Methanocarbathymidine (N-MCT) in Normal Volunteers

NCT02778386 is registered in ClinicalTrials.gov with N&N Pharmaceuticals Inc. as lead sponsor.

NCT NCT02778386
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02778386 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Trial to Assess the Safety and Pharmacokinetics of a Single Ascending Dose (SAD) of N-Methanocarbathymidine (N-MCT) in Normal Volunteers
Lead sponsor
N&N Pharmaceuticals Inc.
Phase
Phase 1
Overall status
Unknown status
Start date
April 30, 2016
Completion date
December 31, 2016
Enrollment
28 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

toxicity